| Page 1813 | Kisaco Research
 

Dr. Saul Priceman

Assistant Research Professor
Department of Hematology & Hematopoietic Cell Transplantation, City of Hope

Dr. Saul Priceman

Assistant Research Professor
Department of Hematology & Hematopoietic Cell Transplantation, City of Hope

Dr. Saul Priceman

Assistant Research Professor
Department of Hematology & Hematopoietic Cell Transplantation, City of Hope
 

Dr. Avery Posey

Department of Pathology and Laboratory Medicine
University of Pennsyvania

Dr. Avery Posey

Department of Pathology and Laboratory Medicine
University of Pennsyvania

Dr. Avery Posey

Department of Pathology and Laboratory Medicine
University of Pennsyvania
 

Dr. Francesco Galimi

Global Product General Manager, Early Development
Amgen Inc

Dr. Francesco Galimi

Global Product General Manager, Early Development
Amgen Inc

Dr. Francesco Galimi

Global Product General Manager, Early Development
Amgen Inc
 

Dr. Leonard Lichtenfeld

Acting Chief Medical Officer
American Cancer Society

Dr. Leonard Lichtenfeld

Acting Chief Medical Officer
American Cancer Society

Dr. Leonard Lichtenfeld

Acting Chief Medical Officer
American Cancer Society
 

Dr. Stefan Scherer

Chief Medical Officer
Cellectis

Dr. Stefan Scherer

Chief Medical Officer
Cellectis

Dr. Stefan Scherer

Chief Medical Officer
Cellectis
 

Hans-Peter Gerber

CSO & SVP
3T Biosciences

Hans-Peter Gerber

CSO & SVP
3T Biosciences

Hans-Peter Gerber

CSO & SVP
3T Biosciences
 

Dr. Christina Coughlin

Chief Medical Officer & Executive Vice President
Tmunity

Dr. Christina Coughlin

Chief Medical Officer & Executive Vice President
Tmunity

Dr. Christina Coughlin

Chief Medical Officer & Executive Vice President
Tmunity
 

Dr. John McHutchinson

Chief Scientific Officer & Head of Research and Development
Gilead

Dr. John McHutchinson

Chief Scientific Officer & Head of Research and Development
Gilead

Dr. John McHutchinson

Chief Scientific Officer & Head of Research and Development
Gilead
 

Dr. Alessandro Riva

Executive Vice President, Oncology Therapeutics
Gilead

Dr. Alessandro Riva

Executive Vice President, Oncology Therapeutics
Gilead

Dr. Alessandro Riva

Executive Vice President, Oncology Therapeutics
Gilead